Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fortrea Holdings Inc. due to allegations of misleading statements and financial misrepresentations that have negatively impacted investors [2][4]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses in Fortrea to contact them regarding their legal rights, particularly for those who purchased securities between July 3, 2023, and February 28, 2025 [1][2]. - There is an August 1, 2025 deadline for investors to seek the role of lead plaintiff in a federal securities class action against Fortrea [2][4]. Group 2: Allegations Against Fortrea - The complaint alleges that Fortrea and its executives violated federal securities laws by making false statements and failing to disclose critical information, including overestimating revenue contributions from Pre-Spin Projects and overstating cost savings from exiting TSAs [4]. - The company's previously announced EBITDA targets for 2025 were inflated, leading to an overstatement of its business model viability and financial prospects [4]. Group 3: Stock Performance and Analyst Downgrades - On September 25, 2024, Jefferies downgraded Fortrea from buy to hold, citing weaknesses in the business model and a stock price drop of $2.73 per share (12.29%) to close at $19.48 [5]. - Following the cancellation of two scheduled conferences, Baird Equity Research downgraded Fortrea to neutral on December 6, 2024, resulting in a stock price decline of $1.90 per share (8.06%) to close at $21.67 [6]. - On March 3, 2025, Fortrea announced disappointing financial results, revealing that its revenue and adjusted EBITDA expectations for 2025 were not met, leading to a significant stock price drop of $3.47 per share (25.05%) to close at $10.38 [7].

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, stemming from allegations of overstating cost savings and revenue projections related to transition services agreements following its spin-off from Labcorp [1][2][4]. Group 1: Company Background - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions [3]. - The company was spun off from Labcorp Holdings Inc. in June 2023, becoming a standalone publicly traded entity [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Fortrea exaggerated the cost savings and margin improvements expected from exiting transition services agreements with Labcorp [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing Q4 and full-year 2024 financial results, revealing lower-than-expected revenue and profitability from pre-spin projects, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

CNBC’s “Fast Money” is joined by Randy Konik, managing director at Jefferies, to discuss Nike’s fiscal fourth-quarter earnings results, which beat expectations on the top and bottom lines. ...

Bank Stress Test & Regulatory Environment - Banks are expected to pass stress tests with flying colors, potentially leading to a shrink in stress capital buffer for some, like NT Bank [2] - The stress test primarily focuses on credit quality and liquidity, but does not adequately address interest rate shock scenarios [9][10] - Deregulation is expected to impact various industries, including banking and energy [13] Investment Banking & Capital Markets - Jefferies indicates resilience in investment banking and capital markets, expressing optimism for the second half of the year [5] - April was a challenging month for investment banking due to tariff news, but performance improved in subsequent months [6] - Investment banking revenues are projected to be down high single digits, while trading revenues driven by equities are expected to be up mid to high single digits; these figures may improve due to strong June performance [7] Mergers & Acquisitions (M&A) - There appears to be a build-up of potential M&A activity due to uncertainty in March and April [12] - The current administration is perceived as supportive of consolidation, including M&A activity across various industries [12][13] Commercial Real Estate (CRE) - The stress test this year has lower credit losses in commercial real estate, which would be another benefit for banks [4] - NT Bank has a higher level of commercial real estate loans than its peers, which previously led to a higher stress capital buffer, but this has been reduced [3]

Core Viewpoint - Jefferies Financial Group's second-quarter fiscal 2025 adjusted earnings of 43 cents per share matched estimates but declined from 67 cents per share in the prior-year quarter, indicating a challenging financial environment [1][9]. Financial Performance - Net income attributable to common shareholders was $88 million, down from $145.7 million in the prior-year quarter, reflecting a significant decrease in profitability [2]. - Quarterly net revenues were $1.63 billion, a decrease of 1.3% year over year, although it surpassed the Zacks Consensus Estimate of $1.56 billion [3]. - Total non-interest expenses rose to $1.50 billion, up 5% from the prior-year quarter, driven by increases in almost all cost components except for compensation and benefits and underwriting costs [3]. Segment Performance - In the Investment Banking and Capital Markets segment, net revenues were $1.47 billion, falling 1.6% from the prior-year quarter due to lower equity and debt underwriting and fixed-income performance, partially offset by strong performance in Equities [5]. - The Asset Management segment reported net revenues of $154.6 million, down 1.2% from the year-ago quarter [5]. Shareholder Returns - Jefferies announced a quarterly cash dividend of 40 cents per share, to be paid on August 29, 2025, to shareholders as of August 18 [6]. Book Value - As of May 31, 2025, the book value per common share was $49.96, an increase from $46.57 as of May 31, 2024, while the adjusted tangible book value per fully diluted share rose to $32.84 from $31.27 [4].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, stemming from allegations of overstating cost savings and revenue projections related to transition services agreements following its spin-off from Labcorp [1][2][4]. Group 1: Company Background - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions [3]. - The company was spun off from Labcorp Holdings Inc. in June 2023, becoming a standalone publicly traded entity [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Fortrea exaggerated the cost savings and margin improvements expected from exiting transition services agreements with Labcorp [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and full year 2024, revealing lower-than-expected revenue and profitability from pre-spin projects, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

Core Viewpoint - Jefferies reported quarterly earnings of $0.43 per share, matching the Zacks Consensus Estimate, but down from $0.67 per share a year ago [1]. Financial Performance - Revenues for the quarter ended May 2025 were $1.63 billion, exceeding the Zacks Consensus Estimate by 5.13%, but down from $1.66 billion year-over-year [2]. - Over the last four quarters, Jefferies has surpassed consensus EPS estimates only once and topped revenue estimates twice [2]. Stock Performance - Jefferies shares have declined approximately 29.4% year-to-date, contrasting with the S&P 500's gain of 3.6% [3]. - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6]. Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.66 on revenues of $1.74 billion, and for the current fiscal year, it is $2.42 on revenues of $6.8 billion [7]. - The trend of earnings estimate revisions is mixed ahead of the earnings release, which may influence future stock movements [6]. Industry Context - The Financial - Miscellaneous Services industry, to which Jefferies belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8].

Core Insights - Jefferies reported a slight decline in total revenue for Q2 FY 2025 compared to Q2 FY 2024, with total revenue at $1.63 billion, down 1% [1] - Adjusted earnings per share fell significantly by 38% to $0.40, missing analysts' expectations [1][2] - Investment banking revenue decreased by 3% year-over-year, while capital markets revenue remained flat [1][3] Financial Performance - Total revenue for Q2 FY 2024 was $1.66 billion, while Q2 FY 2025 saw a decrease to $1.63 billion [1] - Adjusted earnings per share dropped from $0.64 to $0.40, falling short of expectations [1][2] - Investment banking revenue was $787.4 million in Q2 FY 2024 and decreased to $766.3 million in Q2 FY 2025 [1] - Capital markets revenue remained stable at $707.1 million in Q2 FY 2024 and $704.2 million in Q2 FY 2025 [1] Market Reaction - Following the earnings report, Jefferies shares fell nearly 2% in after-hours trading [5] - The stock had previously risen approximately 42% from its April lows but remains down about 29% year-to-date [6] Operational Insights - Jefferies experienced a significant increase in advisory revenue within its investment banking segment, driven by market share gains and higher M&A activity [3] - However, this was offset by a substantial decline in equity underwriting activity, leading to an overall decrease in investment banking sales [3] - In capital markets, equities performed well, particularly in Europe and Asia, while fixed income revenue faced challenges due to market volatility [4] Future Outlook - CEO Richard Handler expressed optimism about the company's prospects, citing resilience in the global economy and strong backlog figures [8] - Increased non-interest expenses, including higher brokerage and clearing fees, contributed to the earnings miss [7]

Financial Performance - Net earnings attributable to common shareholders for Q2 2025 were $88 million, or $0.40 per diluted common share, down from $145.7 million, or $0.64 per diluted common share in Q2 2024[2][10]. - Total net revenues for Q2 2025 were $1.63 billion, a slight decrease from $1.66 billion in Q2 2024, with year-to-date revenues at $3.23 billion compared to $3.39 billion in the previous year[2][10]. - Net earnings attributable to common shareholders for the three months ended May 31, 2025, were $88,017, compared to $145,736 in 2024, a decrease of approximately 39.5%[16]. - Net earnings from continuing operations for the three months ended May 31, 2025, were $91,395,000, a decrease of 40.8% compared to $154,647,000 for the same period in 2024[18]. - The net earnings attributable to common shareholders for basic earnings per share for the six months ended May 31, 2025, was $215,955,000, down from $301,237,000 in the same period of 2024, a decline of 28.4%[18]. Revenue Breakdown - Investment banking net revenues totaled $786 million for Q2 2025, up 6.4% year-over-year, driven by a 61% increase in Advisory revenues[6][10]. - Capital Markets net revenues were $704 million for Q2 2025, slightly down from $707 million in Q2 2024, with Equities net revenues increasing by 24% to $526 million[7][10]. - Asset Management fees and investment return revenues for Q2 2025 were $71 million, a 43% increase from the prior year quarter, attributed to improved performance across several strategies[8][10]. - Total revenues for the three months ended May 31, 2025, were $2,494,315, compared to $2,516,296 for the same period in 2024, reflecting a decrease of approximately 0.9%[16]. - Net revenues for the six months ended May 31, 2025, were $3,227,466, down from $3,394,648 in 2024, representing a decline of about 4.9%[16]. Expenses and Costs - Total non-interest expenses for the three months ended May 31, 2025, were $1,499,546, compared to $1,428,691 in 2024, an increase of approximately 4.9%[16]. - Interest expense for the six months ended May 31, 2025, was $1,739,713, compared to $1,673,590 in 2024, reflecting an increase of about 3.9%[16]. - Compensation and benefits for the three months ended May 31, 2025, were $854,839, compared to $861,993 in 2024, a slight decrease of approximately 0.2%[16]. - Brokerage and clearing fees for the six months ended May 31, 2025, were $239,181, compared to $220,206 in 2024, representing an increase of about 8.6%[16]. Shareholder Metrics - The company declared a quarterly cash dividend of $0.40 per common share, payable on August 29, 2025[3]. - Return on adjusted tangible shareholders' equity from continuing operations was 5.5% for Q2 2025, down from 9.1% in Q2 2024[2][10]. - The book value per common share increased to $49.96 in Q2 2025, up from $46.57 in Q2 2024[2][10]. - The weighted average diluted common shares outstanding for the three months ended May 31, 2025, were 221,897, a decrease from 226,146 in the same period of 2024[18]. - Common shares outstanding as of May 31, 2025, totaled 206,272 thousand, with adjusted fully diluted shares outstanding at 254,564 thousand[22]. Tax and Regulatory - The effective tax rate from continuing operations was 32.3% for Q2 2025, compared to 32.1% for the prior year quarter[10]. - The company reported an income tax expense of $43,506 for the three months ended May 31, 2025, compared to $73,107 in 2024, a decrease of approximately 40.5%[16]. Operational Insights - Management expressed optimism for the second half of 2025, citing a strong backlog and increased client discussions around capital formation and strategic opportunities[4][5]. - The company reported a leverage ratio of 6.5 for the three months ended May 31, 2025, compared to 6.8 for the same period in 2024[17]. - The number of employees at the end of the reporting period was 7,601, a slight increase from 7,577 in the previous year[17]. - Cash and cash equivalents as of May 31, 2025, totaled $1,126,000,000, compared to $1,117,000,000 as of May 31, 2024, reflecting a growth of 0.8%[17]. Discontinued Operations - The company experienced net losses attributable to noncontrolling interests of $7,668,000 for the three months ended May 31, 2025, compared to $3,785,000 in the same period of 2024[18]. - The company experienced a net earnings impact from discontinued operations of $5,861 thousand for the six months ended May 31, 2025[20].